Amelioration of cardiac hypertrophy through inhibition of mTORC1 signaling by histone deacetylase inhibitor

被引：0
|
作者：
Lee, E. [1 ,2 ,3 ]
Kim, I. [1 ,2 ,3 ]
机构：
[1] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[2] Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Daegu, South Korea
[3] Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, PLUS KNU Biomed Convergence Program BK21, Daegu, South Korea
来源：
FEBS OPEN BIO | 2018年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
ShT.03-1
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Pathological Hypertrophy Amelioration by Pras40-mediated Inhibition of Mtorc1
    Volkers, Mirko
    Konstandin, Mathias
    Doroudgar, Shirin
    Glembotski, Christopher
    Sussman, Mark
    CIRCULATION, 2013, 128 (22)
  • [2] Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1
    Voelkers, Mirko
    Toko, Haruhiro
    Doroudgar, Shirin
    Din, Shabana
    Quijada, Pearl
    Joyo, Anya Y.
    Ornelas, Luis
    Joyo, Eri
    Thuerauf, Donna J.
    Konstandin, Mathias H.
    Gude, Natalie
    Glembotski, Christopher C.
    Sussman, Mark A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (31) : 12661 - 12666
  • [3] Histone deacetylase inhibition blunts pathological cardiac hypertrophy
    Kong, YL
    Berenji, K
    Tannous, P
    Rothermel, BA
    Hill, JA
    CIRCULATION, 2004, 110 (17) : 24 - 24
  • [4] Histone deacetylase inhibition blunts pathological cardiac hypertrophy
    Kong, YL
    Lu, GR
    Tannous, P
    Berenji, K
    Rothermel, BA
    Olson, EN
    Hill, JA
    CIRCULATION, 2005, 112 (17) : U119 - U119
  • [5] Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation
    Hasumi, Yukiko
    Baba, Masaya
    Hasumi, Hisashi
    Huang, Ying
    Lang, Martin
    Reindorf, Rachel
    Oh, Hyoung-bin
    Sciarretta, Sebastiano
    Nagashima, Kunio
    Haines, Diana C.
    Schneider, Michael D.
    Adelstein, Robert S.
    Schmidt, Laura S.
    Sadoshima, Junichi
    Linehan, W. Marston
    HUMAN MOLECULAR GENETICS, 2014, 23 (21) : 5706 - 5719
  • [6] AMPK Positively Regulates Neurotensin Secretion Through Inhibition of mTORC1 Signaling
    Song, Jun
    Li, Jing
    Weiss, Heidi L.
    Gao, Tianyan
    Townsend, Courtney M.
    Evers, B. Mark
    GASTROENTEROLOGY, 2014, 146 (05) : S87 - S87
  • [7] Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling
    Glazer, Hilary P.
    Osipov, Robert M.
    Clements, Richard T.
    Sellke, Frank W.
    Bianchi, Cesario
    CELL CYCLE, 2009, 8 (11) : 1738 - 1746
  • [8] AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1
    Li, Yanh
    Chen, Cong
    Yao, Fengj
    Su, Qiao
    Liu, Dan
    Xue, Ruic
    Dai, Gang
    Fang, Rong
    Zeng, Juny
    Chen, Yil
    Huang, Huil
    Ma, Yued
    Li, Wenw
    Zhang, Lil
    Liu, Chen
    Dong, Yug
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 558 : 79 - 86
  • [9] Inhibition of mTORC1 renders cardiac protection against lipopolysaccharide
    Li, Xiang
    Jiang, Lijing
    Lin, Shenghui
    He, Yunfen
    Shen, Guofeng
    Cai, Zhenlin
    Ling, Meirong
    Ni, Jindi
    Zhang, Hao
    Zhang, Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8432 - 8442
  • [10] Spliced X-box Binding Protein 1 Promotes Cardiac Hypertrophy through Activation of mTORC1
    Wang, Xiaoding
    Li, Jianping
    Tran, Diem Hong
    Xu, Lin
    Gillette, Thomas
    Jiang, Xuejun
    Wang, Zhao, V
    CIRCULATION RESEARCH, 2017, 121
12345